← Leaderboards
Jing Wang
University Of Nebraska Medical Center
$7,390,496
Attributed
$7,390,496
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2010–22$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,390,496 · 6
By mechanism
R01$6,760,741 · 4
P20$419,923 · 1
P30$209,832 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Punita Dhawan$3,662,344
- Corey R. Hopkins$7,733,878
- Shyamal K Roy$7,237,756
- Terence A Lawson$1,386,524
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisTransforming Growth Factor BetaMediatingPathway InteractionsCancer CellColorectal CancerSignal TransductionColon CarcinomaMalignant NeoplasmsMolecularCellsMouse ModelTumorBiologicalEffective TherapyEventClinically SignificantClinically RelevantSamplingCancer EtiologyBaseKnock-DownMortalityCancer Therapy
Grant awards (27)
The Functional Role of LGR5 in Colon Cancer$349,713
R01 · FY2022 · CA · contact PI
The Functional Role of GRM3 in Colon Cancer$349,713
R01 · FY2022 · CA · contact PI
The Functional Role of GRM3 in Colon Cancer$356,850
R01 · FY2021 · CA · contact PI
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer$356,850
R01 · FY2021 · CA · contact PI
The Functional Role of LGR5 in Colon Cancer$356,850
R01 · FY2021 · CA · contact PI
The Functional Role of LGR5 in Colon Cancer$356,850
R01 · FY2020 · CA · contact PI
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer$356,850
R01 · FY2020 · CA · contact PI
The Functional Role of GRM3 in Colon Cancer$356,850
R01 · FY2020 · CA · contact PI
Target Validation Core$140,074
P20 · FY2020 · GM · contact PI
Laboratory Services (LS)$53,756
P30 · FY2020 · CA · contact PI
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer$346,144
R01 · FY2019 · CA · contact PI
Target Validation Core$143,124
P20 · FY2019 · GM · contact PI
Laboratory Services (LS)$53,756
P30 · FY2019 · CA · contact PI
The Functional Role of GRM3 in Colon Cancer$356,850
R01 · FY2018 · CA · contact PI
The Functional Role of LGR5 in Colon Cancer$356,850
R01 · FY2018 · CA · contact PI
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer$348,653
R01 · FY2018 · CA · contact PI
Target Validation Core$136,725
P20 · FY2018 · GM · contact PI
Laboratory Services (LS)$55,000
P30 · FY2018 · CA · contact PI
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer$346,366
R01 · FY2017 · CA · contact PI
The Functional Role of LGR5 in Colon Cancer$344,269
R01 · FY2017 · CA · contact PI
The Functional Role of GRM3 in Colon Cancer$344,269
R01 · FY2017 · CA · contact PI
Laboratory Services (LS)$47,320
P30 · FY2017 · CA · contact PI
Mechanisms of TGF beta mediated suppression of metastasis in colon cancer$289,927
R01 · FY2014 · CA · contact PI
Mechanisms of TGF beta mediated suppression of metastasis in colon cancer$280,961
R01 · FY2013 · CA · contact PI
Mechanisms of TGF beta mediated suppression of metastasis in colon cancer$298,894
R01 · FY2012 · CA · contact PI
Mechanisms of TGF beta mediated suppression of metastasis in colon cancer$298,894
R01 · FY2011 · CA · contact PI
Mechanisms of TGF beta mediated suppression of metastasis in colon cancer$308,138
R01 · FY2010 · CA · contact PI